Haematologica高引用文章

• Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

  引用次数：69

• Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

  引用次数：67

• Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX

  引用次数：60

• Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

  引用次数：43

• The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis

  引用次数：40

• Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up

  引用次数：33

• Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in he United States

  引用次数：29

• Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

  引用次数：28

• From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

  引用次数：28

• Thrombopoietin receptor agonists: ten years later

  引用次数：27